Stryker’s Guidance Cut Rattles Investors: What It Really Says About 2027
Published . Updated .
Covered by 2 outlets: 24/7 Wall St., Yahoo Finance.
Who covered it: Center 1 · Not rated 1. How we rate outlets
This report is about the broad US market.
Directly affected
- SYK Stryker+8.6% 30d
Named in this report.
Indirectly affected
- DIA SPDR Dow Jones Industrial Average ETF-1.7% 30d
SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “investors” (the broad US market) in this story.
- QQQ Invesco QQQ+2.3% 19d
Invesco QQQ: it is a broad US stock-market fund. Linked by “investors” (the broad US market) in this story.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Stryker belongs to, so it often moves with news about it.
- MMM 3M+1.5% 30d
3M is a peer of Stryker in surgical and medical instruments and apparatus; rivals often move on the same news.
- BSX Boston Scientific-2.7% 30d
Boston Scientific is a peer of Stryker in surgical and medical instruments and apparatus; rivals often move on the same news.
- BDX Becton, Dickinson and+9.7% 30d
Becton, Dickinson and is a peer of Stryker in surgical and medical instruments and apparatus; rivals often move on the same news.
- MDLN Medline-11.5% 10d
Medline is a peer of Stryker in surgical and medical instruments and apparatus; rivals often move on the same news.
- RMD ResMed+9.5% 30d
ResMed is a peer of Stryker in surgical and medical instruments and apparatus; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| SYK | -1.40% | -3.24% | base | after close | after close | after close | after close |
| DIANo price data for this ticker | — | — | — | — | — | — | — |
| QQQ | -1.57% | +0.81% | base | after close | after close | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| MMMNo price data for this ticker | — | — | — | — | — | — | — |
| BSXNo price data for this ticker | — | — | — | — | — | — | — |
| BDXNo price data for this ticker | — | — | — | — | — | — | — |
| MDLNNo price data for this ticker | — | — | — | — | — | — | — |
| RMDNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Stryker’s Guidance Cut Rattles Investors: What It Really Says About 2027 24/7 Wall St.
Source: 24/7 Wall St.
This story
| Company | When | Move | Status |
|---|---|---|---|
| QQQ | three days earlier | +0.81% | final price |
| QQQ | five days earlier | -1.57% | final price |
| SYK | three days earlier | -3.24% | final price |
| SYK | five days earlier | -1.40% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna sold Stryker (SYK) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 35 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Stryker (SYK) (held by a dependent child), worth $15,001 - $50,000 on 11 Sep 2026. That is 49 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Stryker (SYK) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (jointly held), worth $50,001 - $100,000 on 9 Sep 2026. That is 51 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (jointly held), worth $50,001 - $100,000 on 4 Sep 2026. That is 56 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (held by a dependent child), worth $1,001 - $15,000 on 3 Sep 2026. That is 57 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Resmed (RMD) (held by a dependent child), worth $1,001 - $15,000 on 11 Sep 2026. That is 49 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, sold Resmed (RMD), worth $15,001 - $50,000 on 26 Aug 2026. That is 65 days before publication. Filed 8 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
25 out of 100
“Stryker’s Guidance Cut Rattles Investors: What It Really Says About 2027” scores 25 out of 100. The score uses 2 sources.